Sandra H. Sulzer, Suzanne Prevedel, T. Barrett, Margo Mekjian, Mindy Vincent, Felicia Frabis, Cris Meier, Claire Warnick Shiverdecker, Maren Wright Voss, Paula J. Cook, Erin Fanning Madden
{"title":"Pilot Testing an Asynchronous Online Harm Reduction and Pharmacotherapy Stigma Reduction Training for Substance Use Treatment Professionals","authors":"Sandra H. Sulzer, Suzanne Prevedel, T. Barrett, Margo Mekjian, Mindy Vincent, Felicia Frabis, Cris Meier, Claire Warnick Shiverdecker, Maren Wright Voss, Paula J. Cook, Erin Fanning Madden","doi":"10.1177/00220426231226223","DOIUrl":null,"url":null,"abstract":"Harm reduction and pharmacotherapy approaches to addressing substance use disorder are evidence-based practices for reducing adverse health outcomes. However, professional stigma toward these approaches impedes implementation. In this pilot study, professionals working in substance use treatment services received a 4-hour asynchronous online harm reduction and pharmacotherapy training. Pre- and post-training surveys used Likert-scale questions to assess attitudes and planned actions. Four of the 23 survey items demonstrated a significant change in pre- to post-attitudes and planned actions relating to harm reduction or pharmacotherapy. These items included less attitudinal stigma towards: methadone and buprenorphine ( p = .021), overdose prevention sites/“drug consumption facilities” ( p = .025), and naloxone distribution ( p = .017), as well as lower intent to primarily promote abstinence-based interventions ( p = .007). This study demonstrated that online asynchronous educational interventions show promise for reducing stigmatizing attitudes towards evidence-based practices among substance use treatment professionals.","PeriodicalId":15626,"journal":{"name":"Journal of Drug Issues","volume":"117 24","pages":""},"PeriodicalIF":1.2000,"publicationDate":"2024-01-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Drug Issues","FirstCategoryId":"90","ListUrlMain":"https://doi.org/10.1177/00220426231226223","RegionNum":4,"RegionCategory":"社会学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"SUBSTANCE ABUSE","Score":null,"Total":0}
引用次数: 0
Abstract
Harm reduction and pharmacotherapy approaches to addressing substance use disorder are evidence-based practices for reducing adverse health outcomes. However, professional stigma toward these approaches impedes implementation. In this pilot study, professionals working in substance use treatment services received a 4-hour asynchronous online harm reduction and pharmacotherapy training. Pre- and post-training surveys used Likert-scale questions to assess attitudes and planned actions. Four of the 23 survey items demonstrated a significant change in pre- to post-attitudes and planned actions relating to harm reduction or pharmacotherapy. These items included less attitudinal stigma towards: methadone and buprenorphine ( p = .021), overdose prevention sites/“drug consumption facilities” ( p = .025), and naloxone distribution ( p = .017), as well as lower intent to primarily promote abstinence-based interventions ( p = .007). This study demonstrated that online asynchronous educational interventions show promise for reducing stigmatizing attitudes towards evidence-based practices among substance use treatment professionals.
期刊介绍:
The Journal of Drug Issues (JDI) was incorporated as a nonprofit entity in the State of Florida in 1971. In 1996, JDI was transferred to the Florida State University College of Criminology and Criminal Justice, and the Richard L. Rachin Endowment was established to support its continued publication. Since its inception, JDI has been dedicated to providing a professional and scholarly forum centered on the national and international problems associated with drugs, especially illicit drugs. It is a refereed publication with international contributors and subscribers. As a leader in its field, JDI is an instrument widely used by research scholars, public policy analysts, and those involved in the day-to-day struggle against the problem of drug abuse.